The District General Hospital as a Resource for the Provision of Neurological Services

por Boggild, M D, Bowden, A N, Chadwick, D W, Doran, M, Enevoldson, T, Fletcher, N A, Hart, I, Humphrey, P, Lecky, B R F, Moore, A P, Smith, D, Steiger, M, Williams, I R, Young, C A
Publicado 1996

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer

por Kelley, R K, Hwang, J, Magbanua, M J M, Watt, L, Beumer, J H, Christner, S M, Baruchel, S, Wu, B, Fong, L, Yeh, B M, Moore, A P, Ko, A H, Korn, W M, Rajpal, S, Park, J W, Tempero, M A, Venook, A P, Bergsland, E K
Publicado 2013

Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility

por Dhara, S., Chhangawala, S., Chintalapudi, H., Askan, G., Aveson, V., Massa, A. L., Zhang, L., Torres, D., Makohon-Moore, A. P., Lecomte, N., Melchor, J. P., Bermeo, J., Cardenas, A., Sinha, S., Glassman, D., Nicolle, R., Moffitt, R., Yu, K. H., Leppanen, S., Laderman, S., Curry, B., Gui, J., Balachandran, V. P., Iacobuzio-Donahue, C., Chandwani, R., Leslie, C. S., Leach, S. D.
Publicado 2021